SCHEMBL4472201

SCHEMBL4472201

O=C(Nc1ccccc1)NS(=O)(=O)c1ccc(F)cc1F

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.58
NPC1 O15118 3/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
HTT P42858 2/20 0.58
ACP1 P24666 2/20 0.51
LMNA P02545 1/20 0.50
AVPR2 P30518 1/20 0.50
GPR27 Q9NS67 1/20 0.50
TP53 P04637 2/20 0.48
CYP2C9 P11712 1/20 0.47
KMT2A Q03164 2/20 0.45
GAA P10253 2/20 0.45
CA12 O43570 2/20 0.45
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
CA9 Q16790 2/20 0.45
MEN1 O00255 1/20 0.45
NAMPT P43490 2/20 0.45
POLB P06746 2/20 0.44
EPHX1 P07099 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26111565 0.80 KCNH2 (0.47) POLB
SCHEMBL4457678 0.79 TP53 (0.73) ACP1LMNATP53CYP2C9CA12
SCHEMBL17609451 0.79 PTK2B (0.55) LMNAAVPR2GPR27TP53POLB
SCHEMBL4476659 0.75 KMT2A (0.63) SMN1; SMN2HTTACP1LMNATP53
SCHEMBL8482825 0.75 POLB (0.50) CA12CA1CA2CA9POLB
SCHEMBL17609477 0.74 RAB9A (1.00) RAB9ANPC1SMN1; SMN2HTTLMNA
SCHEMBL4196236 0.73 LMNA (0.78) SMN1; SMN2ACP1LMNATP53CYP2C9
SCHEMBL2303216 0.73 LMNA (0.63) SMN1; SMN2ACP1LMNATP53CYP2C9
SCHEMBL26112980 0.73 KCNH2 (0.53) GAAPOLB
SCHEMBL6297162 0.73 ACP1 (0.57) RAB9ANPC1SMN1; SMN2HTTACP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009067607-A2 COMBINATIONS OF PDE4 INHIBITORS AND ANTIPSYCHOTICS FOR THE TREATMENT OF PSYCHOTIC DISORDERS MEMORY PHARMACEUTICALS CORPORATION (US) 2009-05-28 WO disclosed